Remembering Sid Wolfe; The biotech scorecard for the first quarter

Taking stock of the drug industry, from the lab to the medicine chest

January 2, 2024 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Public Citizen STAT+ | Consumer health advocate Sid Wolfe was a thorn in the side. We're all the better as a result Sid Wolfe, who died Monday, specialized in taking on the Food and Drug Administration and many of the world's biggest drug manufacturers. By Ed Silverman STAT+ | The biotech scorecard for the first quarter: 17 stock-moving events to watch There's lots to watch in the industry in the months ahead, including readouts on Vertex's pain drug and Acadia's anti-psychotic therapy. By Adam Feuerstein STAT+ | Here's who's profiting the most in health care Ahead of the J.P. Morgan Healthcare Conference, STAT looked at who profits the most in health care. More surprising might be who doesn't. By Tara Bannow and Brittany Trang Adobe STAT+ | Pharmacies fear New Year's financial squeeze from Biden administration rule Under a new policy, there will be a period when pharmacies are being billed PBM fees from 2023, and 2024 bills are piling up at the same time. By Rachel Cohrs

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser